Cost Of Sales 변화 날짜
AbbVie USD 4.28B 90M 2023-12
Abbott USD 4.56B 49M 2023-12
ALKERMES USD 61.51M 1.75M 2023-09
Amgen USD 3.11B 1.31B 2023-12
AstraZeneca USD 2.06B 91M 2023-09
Biogen USD 618.3M 41.3M 2023-12
BioMarin Pharmaceutical USD 135.48M 10.73M 2023-12
Bristol-Myers Squibb USD 2.71B 217M 2023-12
Eisai JPY 36.43B 7.49B 2023-09
Eli Lilly USD 1.79B 72.1M 2023-12
Gilead Sciences USD 1.61B 46M 2023-12
GlaxoSmithKline GBP 2.24B 343M 2023-09
Infinity Pharmaceuticals USD 352K 89K 2023-06
J&J USD 6.8B 418M 2023-12
Merck USD 3.34B 891M 2023-12
Neurocrine Biosciences USD 11.2M 300K 2023-09
Pacira USD 47.69M 7.94M 2023-12
Perrigo USD 712.6M 52.5M 2023-09
Pfizer USD 6.66B 2.24B 2023-12
Regeneron Pharmaceuticals USD 517M 80.6M 2023-12
Revance Therapeutics USD 19.41M 1.89M 2023-09
Roche Holding CHF 7.62B 1.33B 2023-06
UCB EUR 802M 27M 2023-06
Ultragenyx Pharmaceutical USD 12.05M 1.06M 2023-12
United Therapeutics USD 71M 900K 2023-12
Vertex Pharmaceuticals USD 318.7M 10.1M 2023-09
Zoetis USD 726M 89M 2023-12



AbbVie 매출원가 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Mar 2024.